Examining the Expression of miR-205 and CEA mRNA in Peripheral Blood of Patients with OSCC(Oral Squamous Cell Carcinomas) and Comparing them with Healthy People
DOI:
https://doi.org/10.31557/apjcb.2019.4.3.65-68Keywords:
Oral Squamous Cell Carcinoma, Early Detection, miR-205, CEAAbstract
Introduction: Cancer is one of the most important causes of mortality in the world. So, in this study the changes of expressing miR-205 and CEA in oral cancer in peripheral blood were examined for early detection and better treatment.
Methods: In this study, we selected the number of 30 patient people and 30 healthy people. We measured their blood miR-205 and CEA using Real-Time PCR technique and evaluated the relationship between the expression of these biomarkers with tumor staging and cancer progression.
Findings: there is no a significant difference in mean age by comparing these two groups using t-test. The CEA mRNA biomarker was positive in 24 out of 30 people of the patient people group and was positive in 4 out of 30 people of the healthy people group. Statistical comparison represented a statistically significant difference between the two groups (P-value <0.001). The miR-205 biomarker was positive in 9 out of 30 people of the patient people group and was positive in 22 out of 30 people of the healthy people group. Statistical comparison represented a statistically significant difference the two groups (P-value <0.001).
Conclusion: In general, the research result can be considered as a screening test for early detection of the disease in the early stages. It is recommended to conduct more extensive studies with larger sample sizes to further proof of the research results.
References
Vogelstein B, Kinzler KW. Cancer genes and the pathways they control. Nature medicine. 2004;10(8):789.
Screening P, Board PE. Cancer Prevention Overview (PDQ®). 2017.
Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. International journal of cancer. 2015;136(5):E359-E86.
Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA: a cancer journal for clinicians. 2013;63(1):11-30.
Massano J, Regateiro FS, Januário G, Ferreira A. Oral squamous cell carcinoma: review of prognostic and predictive factors. Oral surgery, oral medicine, oral pathology, oral radiology, and endodontology. 2006;102(1):67-76.
Jou Y-J, Lin C-D, Lai C-H, Tang C-H, Huang S-H, Tsai M-H, et al. Salivary zinc finger protein 510 peptide as a novel biomarker for detection of oral squamous cell carcinoma in early stages. Clinica Chimica Acta. 2011;412(15-16):1357-65.
Ribeiro KdCB, Kowalski LP, de Oliveira MdRD. Perioperative complications, comorbidities, and survival in oral or oropharyngeal cancer. Archives of Otolaryngology–Head & Neck Surgery. 2003;129(2):219-28.
Thomas C, Gustafsson J-Å. The different roles of ER subtypes in cancer biology and therapy. Nature Reviews Cancer. 2011;11(8):597.
Zehentner BK, Dillon DC, Jiang Y, Xu J, Bennington A, Molesh DA, et al. Application of a multigene reverse transcription-PCR assay for detection of mammaglobin and complementary transcribed genes in breast cancer lymph nodes. Clinical chemistry. 2002;48(8):1225-31.
Ruan K, Fang X, Ouyang G. MicroRNAs: novel regulators in the hallmarks of human cancer. Cancer letters. 2009;285(2):116-26.
Kanellopoulou C, Monticelli S, editors. A role for microRNAs in the development of the immune system and in the pathogenesis of cancer. Seminars in cancer biology; 2008: Elsevier.
Kim M, Kasinski AL, Slack FJ. MicroRNA therapeutics in preclinical cancer models. The lancet oncology. 2011;12(4):319-21.
Montano M. MicroRNAs: miRRORS of health and disease. Translational research. 2011;157(4):157-.
Sethi N, Wright A, Wood H, Rabbitts P. MicroRNAs and head and neck cancer: reviewing the first decade of research. European Journal of Cancer. 2014;50(15):2619-35.
Wiemer EA. The role of microRNAs in cancer: no small matter. European journal of cancer. 2007;43(10):1529-44.
Wagener C, Müller-Wallraf R, Nisson S, Gröner J, Breuer H. Localization and concentration of carcinoembryonic antigen (CEA) in gastrointestinal tumors: correlation with CEA levels in plasma. Journal of the National Cancer Institute. 1981;67(3):539-47.
Bishop JM. Molecular themes in oncogenesis. Cell. 1991;64(2):235-48.
Li J, Huang H, Sun L, Yang M, Pan C, Chen W, et al. MiR-21 indicates poor prognosis in tongue squamous cell carcinomas as an apoptosis inhibitor. Clinical cancer research. 2009;15(12):3998-4008.
Avissar M, Christensen BC, Kelsey KT, Marsit CJ. MicroRNA expression ratio is predictive of head and neck squamous cell carcinoma. Clinical Cancer Research. 2009;15(8):2850-5.
Logan J, Logan JM, Edwards KJ, Saunders NA. Real-time PCR: current technology and applications: Horizon Scientific Press; 2009.
Zheng Y, Cui L, Sun W, Zhou H, Yuan X, Huo M, et al. MicroRNA-21 is a new marker of circulating tumor cells in gastric cancer patients. Cancer biomarkers. 2012;10(2):71-7.
Wong T-S, Liu X-B, Wong BY-H, Ng RW-M, Yuen AP-W, Wei WI. Mature miR-184 as potential oncogenic microRNA of squamous cell carcinoma of tongue. Clinical Cancer Research. 2008;14(9):2588-92.
Lin S-C, Liu C-J, Lin J-A, Chiang W-F, Hung P-S, Chang K-W. miR-24 up-regulation in oral carcinoma: positive association from clinical and in vitro analysis. Oral oncology. 2010;46(3):204-8.
Liu CJ, Lin SC, Yang CC, Cheng HW, Chang KW. Exploiting salivary miR‐31 as a clinical biomarker of oral squamous cell carcinoma. Head & neck. 2012;34(2):219-24.
Vizcarra, E., et al., CA 15.3, CEA and TPA tumor markers in the early diagnosis of breast cancer relapse. Oncology, 1994. 51(6): p. 491-6.
Cesario A, Ferri L, Galetta D, Cardaci V, Biscione G, Pasqua F, et al. Pre-operative pulmonary rehabilitation and surgery for lung cancer. Lung Cancer. 2007;57(1):118-9.
Zhu G, Liu D, Wang X, Chen J. Detection of CK19 and CEA mRNA expression for the diagnosis of peripheral blood micrometastases in patients with non-small cell lung cancer. Zhongguo Fei Ai Za Zhi. 2004 Jun 20;7(3):226-9.
Iorio MV, Ferracin M, Liu CG, et al. MicroRNA gene expression deregulation in human breast cancer. Cancer Res 2005;65:7065-70.
Liu J, Mao Q, Liu Y, Hao X, Zhang S, Zhang J.Analysis of miR-205 and miR-155 expression in the blood of breast cancer patients. Chin J Cancer Res 2013;25(1):46-54.
Downloads
Published
Issue
Section
License
West Asia Organization for Cabcer Prevention retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License 4 (This permits anyone to copy, distribute, transmit and adapt the published work, provided the original work and source are appropriately cited).
3.jpg)
